Metoprolol tartrate and Hyperphosphataemia - a phase IV clinical study of FDA data
Summary:
Hyperphosphataemia is reported as a side effect among people who take Metoprolol tartrate (metoprolol tartrate), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Lantus, and have Type 2 diabetes.
The phase IV clinical study analyzes which people have Hyperphosphataemia when taking Metoprolol tartrate. It is created by eHealthMe based on reports of 83,460 people who have side effects when taking Metoprolol tartrate from the FDA, and is updated regularly.
What is Metoprolol tartrate?
Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 89,747 Metoprolol tartrate users. Check the latest studies of Metoprolol tartrate.
What is Hyperphosphataemia?
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood) is found to be associated with 429 drugs and 377 conditions by eHealthMe. Check the latest studies of Hyperphosphataemia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
83,460 people reported to have side effects when taking Metoprolol tartrate.
Among them, 30 people (0.04%) have Hyperphosphataemia.

Among these 30 people:
How long have people been on Metoprolol tartrate when they have Hyperphosphataemia? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hyperphosphataemia when taking Metoprolol tartrate? *
- female: 43.33 %
- male: 56.67 %
What is the age of people who have Hyperphosphataemia when taking Metoprolol tartrate? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 3.45 %
- 40-49: 13.79 %
- 50-59: 44.83 %
- 60+: 37.93 %
What are other drugs people take besides Metoprolol tartrate? *
- Lasix: 8 people, 26.67%
- Lisinopril: 8 people, 26.67%
- Renagel: 8 people, 26.67%
- Lantus: 8 people, 26.67%
- Amlodipine: 6 people, 20.00%
- Furosemide: 4 people, 13.33%
- Prevacid: 4 people, 13.33%
- Prednisone: 4 people, 13.33%
- Protonix: 4 people, 13.33%
- Doxazosin Mesylate: 4 people, 13.33%
What are other side effects people have besides Hyperphosphataemia? *
- Acute Kidney Failure: 12 people, 40.00%
- Hyperkalemia (damage to or disease of the kidney): 11 people, 36.67%
- Diarrhea: 8 people, 26.67%
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 8 people, 26.67%
- Fever: 5 people, 16.67%
- Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 5 people, 16.67%
- Nausea (feeling of having an urge to vomit): 4 people, 13.33%
- Dehydration (dryness resulting from the removal of water): 4 people, 13.33%
- Chronic Kidney Disease: 4 people, 13.33%
- Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 3 people, 10.00%
What are the existing conditions these people have? *
- Type 2 Diabetes: 7 people, 23.33%
- Chronic Kidney Disease: 6 people, 20.00%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 5 people, 16.67%
- Pain: 5 people, 16.67%
- High Blood Cholesterol: 4 people, 13.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 13.33%
- Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 6.67%
- Stress And Anxiety: 2 people, 6.67%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 6.67%
- Calcium Deficiency (lack of calcium): 2 people, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Metoprolol tartrate and have Hyperphosphataemia?
- Check whether Hyperphosphataemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Metoprolol tartrate:
- Metoprolol tartrate (89,747 reports)
Hyperphosphataemia treatments and more:
- Hyperphosphataemia (9,764 reports)
How severe was Hyperphosphataemia and when was it recovered:
Expand to all the drugs that have ingredients of metoprolol tartrate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Metoprolol tartrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperphosphataemia:
- Hyperphosphataemia (429 drugs)
Browse all the conditions that are associated with Hyperphosphataemia:
- Hyperphosphataemia (377 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Metoprolol tartrate) and Metoprolol tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zosyn and Back Pain Aggravated for Men aged 60+ - 5 seconds ago
- Gemcitabine Hydrochloride and Arthropathy for Women aged 60+ - 20 seconds ago
- Could Methotrexate cause Oesophageal Perforation? - 25 seconds ago
- Could Methyldopa cause Heart Palpitations? - 26 seconds ago
- Could Methotrexate cause Gingivitis? - 26 seconds ago
- Could Metformin cause Sedation? - 28 seconds ago
- Could Methimazole cause Platelet Count Increased? - 28 seconds ago
- Could Chlorpromazine Hydrochloride cause Polyserositis? - 41 seconds ago
- Tymlos and Ear Discomfort for Women aged 60+ - 42 seconds ago
- Drug interactions of Azithromycin and Glucagon - a minute ago